Anmeldung erfolgt in Kürze...
Details werden geladen...
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation | The Manila Times
American Journal of Transplantation publishes public pre-proof showing novel CM-score superior to either fractional or absolute measurement of dd-cfDNA aloneGraftAssure™ assay doubles reliability of positive results in screening cohortIn for-cause testing of kidney transplant patients, the positive predictive value using the CM-Score increased to greater than 80% NASHVILLE, Tenn., June 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced an online published article in the American Journal of Transplantation asserting statistical superiority of the company’s flagship GraftAssure transplant rejection monitoring assay.
Ähnliche Seiten
Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress | The Manila ...
https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/eledon-pharmaceuticals-to-present-new-long-term-data-from-phase-2-bestow-trial-of-tegoprubart-for-the-prevention-of-rejection-in-kidney-transplantation-at-american-transplant-congress/2348640iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress | The Manila Times
https://www.manilatimes.net/2026/06/10/tmt-newswire/globenewswire/imdx-to-highlight-in-house-transplant-testing-opportunity-and-host-key-opinion-leaders-at-american-transplant-congress/2362166
New CAR T treatment opens doors for patients in need of kidney transplant | EurekAlert!
https://www.eurekalert.org/news-releases/1130303